Literature DB >> 15483011

Phase II studies of modern drugs directed against new targets: if you are fazed, too, then resist RECIST.

Mark J Ratain, S Gail Eckhardt.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15483011     DOI： 10.1200/JCO.2004.07.960

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  87 in total

1.  Optimized management of advanced hepatocellular carcinoma: four long-lasting responses to sorafenib.

Authors:  Giovanni Abbadessa; Lorenza Rimassa; Tiziana Pressiani; Cynthia Carrillo-Infante; Emanuele Cucchi; Armando Santoro
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Tumor status at 12 weeks predicts survival in advanced colorectal cancer: findings from NCCTG N9741.

Authors:  James M Heun; Axel Grothey; Megan E Branda; Richard M Goldberg; Daniel J Sargent
Journal:  Oncologist       Date:  2011-05-31

3.  Evaluation of molecular targeted cancer drug by changes in tumor marker doubling times.

Authors:  Kenichiro Enooku; Ryosuke Tateishi; Fumihiko Kanai; Yuji Kondo; Ryota Masuzaki; Tadashi Goto; Shuichiro Shiina; Haruhiko Yoshida; Masao Omata; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2011-09-21       Impact factor: 7.527

Review 4.  Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts.

Authors:  Hee Kang; Ho Yun Lee; Kyung Soo Lee; Jae-Hun Kim
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

Review 5.  Bringing Model-Based Prediction to Oncology Clinical Practice: A Review of Pharmacometrics Principles and Applications.

Authors:  Núria Buil-Bruna; José-María López-Picazo; Salvador Martín-Algarra; Iñaki F Trocóniz
Journal:  Oncologist       Date:  2015-12-14

6.  Resampling phase III data to assess phase II trial designs and endpoints.

Authors:  Manish R Sharma; Theodore G Karrison; Yuyan Jin; Robert R Bies; Michael L Maitland; Walter M Stadler; Mark J Ratain
Journal:  Clin Cancer Res       Date:  2012-01-27       Impact factor: 12.531

7.  Three-dimensional Image-based Mechanical Modeling for Predicting the Response of Breast Cancer to Neoadjuvant Therapy.

Authors:  Jared A Weis; Michael I Miga; Thomas E Yankeelov
Journal:  Comput Methods Appl Mech Eng       Date:  2016-09-01       Impact factor: 6.756

8.  Automated tracking of quantitative assessments of tumor burden in clinical trials.

Authors:  Daniel L Rubin; Debra Willrett; Martin J O'Connor; Cleber Hage; Camille Kurtz; Dilvan A Moreira
Journal:  Transl Oncol       Date:  2014-02-01       Impact factor: 4.243

Review 9.  The role of functional imaging in the era of targeted therapy of renal cell carcinoma.

Authors:  Margarita Braunagel; Anno Graser; Maximilian Reiser; Mike Notohamiprodjo
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

Review 10.  Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract.

Authors:  Alberto Diaz de Leon; Daniel Costa; Ivan Pedrosa
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.